Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04603677 · ClinicalTrials.gov registry record

Northern Colorado COVID-19 Biobank

A clinical trial of Covid19, sponsored by Colorado State University.

Completed
Registry status
148
Enrollment target
4
Study locations

NCT04603677 is a study of Covid19 that has completed, run by Colorado State University. The registered enrollment target is 148 participants, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04603677, a study of Covid19, has completed, sponsored by Colorado State University.

COMPLETED
Registry status
148 participants
Enrollment target
4
Study locations

Study Summary

The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.

Conditions Studied

Study Locations (4)

Colorado

  • Colorado State University - Fort Collins
  • Poudre Valley Hospital, UCHealth - Fort Collins
  • Greeley Hospital, UCHealth - Greeley
  • Medical Center of the Rockies, UCHealth - Loveland

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2020-07-08
Est. Completion 2023-02-28

Sponsor

Colorado State University

94 total trials

What the Registry Record Tells You About NCT04603677

The ClinicalTrials.gov registry entry for NCT04603677 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (95% lower). The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 0 interventions.

NCT04603677 reports 4 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04603677 about?

NCT04603677 is a clinical study titled "Northern Colorado COVID-19 Biobank". The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.

What is the current status of trial NCT04603677?

This trial is currently completed. The enrollment target is 148 participants. The study started on 2020-07-08. Estimated completion is 2023-02-28.

What conditions does trial NCT04603677 study?

This clinical trial studies the following conditions: Covid19.

Who is sponsoring clinical trial NCT04603677?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04603677 being conducted?

This trial has 4 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Covid19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.